- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 27.77M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 27.83M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 27.07M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $517.88K |
| Capex | Q1 2026 · Mar 31, 2026 | $784.51K |
| Capex | Q1 2026 · Mar 31, 2025 | $2.64M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.98M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.63M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $49.38M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $54.03M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $19.69M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $20.3M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $9.76M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $14.29M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $305.73M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $311.39M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $335.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $337.98M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $65.51M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $63.9M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $160.7M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $166.59M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $69.61M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $71.4M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $466.44M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $477.98M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.23 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.23 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.36M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $4.1M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.49M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.19M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.93M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.36M |